2,107
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study

, , ORCID Icon, , , & show all
Pages 538-544 | Received 27 May 2017, Accepted 13 Aug 2017, Published online: 29 Aug 2017

References

  • Sugarbaker PH. (1995). Peritonectomy procedures. Ann Surg 221:29–42.
  • Lee L, Alie-Cusson F, Dube P, et al. (2017). Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. J Surg Oncol 116:236–24.
  • Bhatt A, Sheshadri D, Chandan G, et al. (2017). Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: a preliminary five-year experience. J BUON 22:251–7.
  • Schneider MA, Eshmuminov D, Lehmann K. (2017). Major postoperative complications are a risk factor for impaired survival after CRS/HIPEC. Ann Surg Oncol 24:2224–32.
  • Owusu-Agyemang P, Cata JP, Fournier KF, et al. (2016). Evaluating the impact of total intravenous anesthesia on the clinical outcomes and perioperative NLR and PLR profiles of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 23:2419–29.
  • Walsh M, Devereaux PJ, Garg AX, et al. (2013). Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119:507–15.
  • Coccolini F, Corbella D, Finazzi P, et al. (2016). Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol 82:310–9.
  • Ceresoli M, Coccolini F, Ansaloni L. (2016). HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol 42:909–10.
  • Kusamura S, Baratti D, Younan R, et al. (2007). Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 14:2550–8.
  • Glehen O, Osinsky D, Cotte E, et al. (2003). Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–9.
  • Bouhadjari N, Gabato W, Calabrese D, et al. (2016). Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol 42:219–23.
  • Saxena A, Valle SJ, Liauw W, et al. (2017). Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 115:417–24.
  • Plackett TP, Ton-That HH, Mosier MJ, et al. (2017). Physiologic response to HIPEC: sifting through perturbation to identify markers of complications. J Am Osteopath Assoc 117:16–23.
  • Moon T, Tsai JY, Vachhani S, et al. (2016). The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J Cardiothorac Vasc Anesth 30:51–5.
  • Ishikawa S, Griesdale DE, Lohser J. (2012). Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg 114:1256–62.
  • Hosmer DW, Lemeshow S. (2014). Logistic regression models for the analysis of correlated data. In: Hosmer DWL, LemeshowS, eds. Applied logistic regression. 3rd ed. Canada: John Wiley & Sons, 213.
  • Hamilton TD, Taylor EL, Cannell AJ, et al. (2016). Impact of major complications on patients' quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 23:2946–52.
  • Arjona-Sanchez A, Cadenas-Febres A, Cabrera-Bermon J, et al. (2016). Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances. Eur J Surg Oncol 42:869–76.
  • Verwaal VJ, van Tinteren H, Ruth SV, et al. (2004). Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85:61–7.
  • Hakeam HA, Breakiet M, Azzam A, et al. (2014). The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail 36:1486–91.
  • Bouhadjari N, Gabato W, Calabrese D, et al. (2016). Reply letter to: HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol 42:907–8.
  • Ansaloni L, Coccolini F, Morosi L, et al. (2015). Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer 112:306–12.
  • Raspe C, Flother L, Schneider R, et al. (2016). Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 43:1013–27.
  • Launay-Vacher V, Rey JB, Isnard-Bagnis C, et al. (2008). Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol 61:903–9.
  • Wickman C, Kramer H. (2013). Obesity and kidney disease: potential mechanisms. Semin Nephrol 33:14–22.
  • Sin EIL, Chia CS, Tan GHC, et al. (2017). Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia 33:690–5.
  • Pathak RA, Taylor AS, Alford S, et al. (2015). Urologic-induced complications of prophylactic ureteral localization stent placement for colorectal surgery cases. J Laparoendosc Adv Surg Tech A25:966–70.
  • Adediran S, Dhakarwal P. (2014). Reflex anuria: a rare cause of acute kidney injury. J Community Hosp Intern Med Perspect 4:23423.
  • Weinstein JR, Anderson S. (2010). The aging kidney: physiological changes. Adv Chronic Kidney Dis 17:302–7.
  • Sobamowo H, Prabhakar SS. (2017). The kidney in aging: physiological changes and pathological implications. Prog Mol Biol Transl Sci 146:303–40.
  • Cata JP, Zafereo M, Villarreal J, et al. (2015). Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth 27:672–9.
  • Haas M, Segev DL, Racusen LC, et al. (2008). Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med 132:37–42.
  • Khalil H. (2016). Diabetes microvascular complications – a clinical update. Diabetes Metab Syndr. [Epub ahead of print]. doi: 10.1016/j.dsx.2016.12.022.
  • Moshiri M, Moallem SA, Attaranzadeh A, et al. (2017). Injury to skeletal muscle of mice following acute and sub-acute pregabalin exposure. Iran J Basic Med Sci 20:256–9.
  • Falconi D, Tattoli F, Brunetti C, et al. (2015). [Rhabdomyolysis from gabapentin: a case report]. G Ital Nefrol. 32(2):pii: gin/32.2.37.
  • Barmparas G, Lamb AW, Lee D, et al. (2015). Postoperative infection risk after splenectomy: a prospective cohort study. Int J Surg 17:10–4.
  • Andres-Hernando A, Altmann C, Ahuja N, et al. (2011). Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice. Am J Physiol Renal Physiol 301:F907–16.
  • Jiang H, Meng F, Li W, et al. (2007). Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 141:32–40.
  • Ajmo CT, Jr., Vernon DO, Collier L, et al. (2008). The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 86:2227–34.
  • Wystrychowski W, Filipczyk L, Cierpka L, et al. (2014). Splenectomy attenuates the course of kidney ischemia-reperfusion injury in rats. Transplant Proc 46:2558–61.
  • Macedo E, Bouchard J, Soroko SH, et al. (2010). Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 14:R82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.